Abstract 2769: Bradycardia-Dependent Augmentation of J-wave Elevation in Patients with Idiopathic Ventricular Fibrillation

Circulation ◽  
2008 ◽  
Vol 118 (suppl_18) ◽  
Author(s):  
Koichi Mizumaki ◽  
Akira Fujiki ◽  
Masao Sakabe ◽  
Tamotsu Sakamoto ◽  
Yosuke Nakatani ◽  
...  

Although J-wave elevation (JWE) in the inferior or lateral leads is characteristic of subtype of idiopathic ventricular fibrillation (IVF), difference between malignant and benign JWE remains to be elucidated. So, we assessed the hypothesis that the rate dependent changes in JWE could be different between patients with IVF and control subjects. Six male patients with IVF and 18 age matched male controls with JWE (>2 mm) in the lateral leads were studied. CM-5 lead digital Holter ECG was recorded and J wave amplitude was automatically measured. J/RR relationships were evaluated by means of J/RR linear regression lines for 24 hours, and according to four 6-hour periods. From J-RR linear regression lines, J-RR slope (mm/sec), J wave amplitude (mm) at RR intervals of both 0.6 sec and 1.2 sec (J (0.6) and J (1.2) ) were determined. In all 6 patients with IVF, the time of spontaneous episodes of VF were investigated from the implantable cardioverter defibrillator (ICD) stored data. For 24 hours, J-RR slope was greater in IVF patients than in controls (3.5±0.7 vs 2.4±0.8, p<0.01). (J (0.6) ) wasn’t different between 2 groups; however, J (1.2) was greater in IVF patients than in controls (2.8±0.9 vs 2.0±0.6, p<0.05). In IVF patients, ST/RR slope was highest during 18:00–24:00; however, these circadian changes were blunted in controls. J(1.2) was greater during 18:00 – 6:00 in IVF patients than in controls. Seven (59%) of total 9 episodes of spontaneous VF of IVF patients occurred during 18:00 – 6:00. In patients with subtype of IVF, JWE augmented during bradycardia especially at night. This could relate to nighttime occurrence of IVF.

Heart Rhythm ◽  
2012 ◽  
Vol 9 (2) ◽  
pp. 249-255 ◽  
Author(s):  
Koichi Mizumaki ◽  
Kunihiro Nishida ◽  
Jotaro Iwamoto ◽  
Yosuke Nakatani ◽  
Yoshiaki Yamaguchi ◽  
...  

2013 ◽  
Vol 77 (2) ◽  
pp. 330-337 ◽  
Author(s):  
Hiroko Miyazaki ◽  
Mikiko Nakagawa ◽  
Yukie Shin ◽  
Osamu Wakisaka ◽  
Tetsuji Shinohara ◽  
...  

2011 ◽  
Vol 35 (8) ◽  
pp. e226-e230 ◽  
Author(s):  
MASAOMI CHINUSHI ◽  
KANAE HASEGAWA ◽  
KENICHI IIJIMA ◽  
HIROSHI FURUSHIMA ◽  
DAISUKE IZUMI ◽  
...  

2012 ◽  
Vol 9 (2) ◽  
pp. 143-147 ◽  
Author(s):  
Wang Jing ◽  
Tang Min ◽  
Mao Ke-Xiu ◽  
Chu Jian-Min ◽  
Hua Wei ◽  
...  

2011 ◽  
Vol 27 (Supplement) ◽  
pp. PJ2_084
Author(s):  
Tomoaki Sakakibara ◽  
Hayato Ohtani ◽  
Yasushi Wakabayashi ◽  
Makoto Sano ◽  
Tsuyoshi Urushida ◽  
...  

2019 ◽  
Vol 11 (4) ◽  
pp. 699-709 ◽  
Author(s):  
Michel Haïssaguerre ◽  
Wee Nademanee ◽  
Mélèze Hocini ◽  
Josselin Duchateau ◽  
Clementine André ◽  
...  

EP Europace ◽  
2019 ◽  
Vol 21 (10) ◽  
pp. 1519-1526
Author(s):  
Lennart J Blom ◽  
Marloes Visser ◽  
Imke Christiaans ◽  
Marcoen F Scholten ◽  
Marianne Bootsma ◽  
...  

Abstract Aims Idiopathic ventricular fibrillation (IVF) is a rare cause of sudden cardiac arrest. Implantable cardioverter-defibrillator (ICD) implantation is currently the only treatment option. Limited data are available on the prevalence and complications of ICD therapy in these patients. We sought to investigate ICD therapy and its complications in patients with IVF. Methods and results Patients were selected from a national registry of IVF patients. Patients in whom no underlying diagnosis was found during follow-up were eligible for inclusion. Recurrence of ventricular arrhythmia (VA) was derived from medical and ICD records, electrogram records of ICD therapies were used to differentiate between appropriate or inappropriate interventions. Independent predictors for appropriate ICD shock were calculated using cox regression. In 217 IVF patients, recurrence of sustained VAs occurred in 66 patients (30%) during a median follow-up period of 6.1 years. Ten patients died (4.6%). Thirty-eight patients (17.5%) experienced inappropriate ICD therapy, and 32 patients (14.7%) had device-related complications. Symptoms before cardiac arrest [hazard ratio (HR): 2.51, 95% confidence interval (CI): 1.48–4.24], signs of conduction disease (HR: 2.27, 95% CI: 1.15–4.47), and carrier of the DPP6 risk haplotype (HR: 3.24, 1.70–6.17) were identified as independent predictors of appropriate shock occurrence. Conclusion Implantable cardioverter-defibrillator therapy is an effective treatment in IVF, treating recurrences of potentially lethal VAs in approximately one-third of patients during long-term follow-up. However, device-related complications and inappropriate shocks were also frequent. We found significant predictors for appropriate ICD therapy. This may imply that these patients require additional management to prevent recurrent events.


Sign in / Sign up

Export Citation Format

Share Document